Concourse Financial Group Securities’s Cardlytics CDLX Stock Holding History

Concourse Financial Group Securities’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4	Closed	-$4.06K	–	2411
2021 Q2	$5K	Hold	4	–	–	﹤0.01%	2035
2021 Q1	$4K	Hold	4	–	–	﹤0.01%	2005
2020 Q4	$6K	Hold	4	–	–	﹤0.01%	1836
2020 Q3	$3K	Hold	4	–	–	﹤0.01%	1922
2020 Q2	$3K	Hold	4	–	–	﹤0.01%	1811
2020 Q1	$1K	Sell	4 -1	-20%	-$708	﹤0.01%	2006
2019 Q4	$3K	Buy	+5	New	+$2.44K	﹤0.01%	1748

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

ACM

Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Concourse Financial Group Securities's CDLX Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 4 shares — an estimated $4.06K sold.

Concourse Financial Group Securities first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $6K in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

Concourse Financial Group Securities reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
Concourse Financial Group Securities sold 4 Cardlytics shares in Q3 2021, an estimated $4.06K.
Concourse Financial Group Securities first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
Concourse Financial Group Securities's Cardlytics position peaked at $6K in Q4 2020.
164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.